+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neuroscience Market by Product Type, Technology, Application, End User - Global Forecast to 2030- Product Image
Neuroscience Market by Product Type, Technology, Application, End User - Global Forecast to 2030- Product Image
Sale

Neuroscience Market by Product Type, Technology, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5889272
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Neuroscience Market grew from USD 15.11 billion in 2024 to USD 16.77 billion in 2025. It is expected to continue growing at a CAGR of 10.45%, reaching USD 27.45 billion by 2030.

Setting the Stage for Neuroscience Market Evolution

The global neuroscience market stands at the threshold of a new era defined by rapid technological innovation and evolving clinical demands. An accelerating convergence of advanced imaging, precise monitoring solutions, and therapeutic interventions is reshaping the ways researchers and clinicians navigate complex neurological conditions. Against this backdrop, a deeper understanding of market drivers, competitive dynamics, and emerging applications has become indispensable for stakeholders seeking to capitalize on high-value opportunities.

This executive summary distills the most critical insights needed to navigate the current landscape. It highlights the forces propelling adoption of imaging devices such as computed tomography, electroencephalography, and magnetic resonance systems while charting the rise of noninvasive monitoring tools and neuromodulation therapies. Complementing these hardware trends, the integration of consultancy and maintenance services with sophisticated analysis and visualization software has transformed the scope of solutions available to end users. By framing these developments alongside regulatory shifts and cost pressures, this introduction sets the stage for a deeper exploration of strategic imperatives in the neuroscience domain.

Embracing Pivotal Transformations Shaping the Industry

The neuroscience landscape is undergoing transformative shifts that extend from breakthroughs in functional diagnostics to the commercialization of personalized interventions. Artificial intelligence and machine learning now enable more accurate interpretation of complex imaging data, accelerating diagnostic workflows and reducing time to intervention. At the same time, robust collaborations between medical device firms and software developers are driving a seamless fusion of hardware and analytical platforms.

Regulatory bodies are simultaneously adapting guidelines to accommodate novel technologies such as functional near infrared spectroscopy and magnetoencephalography, fostering a climate of innovation while emphasizing patient safety. Telemedicine and remote monitoring have gained prominence due to evolving care models, prompting device manufacturers to enhance portability and user-friendly design. These converging forces are defining a new paradigm where agility, data-driven insights, and integrated service offerings become critical for long-term success.

Assessing the Ramifications of United States Tariffs in 2025

The introduction of new United States tariffs in 2025 has introduced additional cost considerations across the supply chain of neuroscience equipment and software. Imported imaging devices and key components used in electroencephalography and computed tomography systems now carry higher duties, leading manufacturers to reassess sourcing, production, and pricing strategies. In response, several firms have accelerated domestic production plans to mitigate the impact of these levies and maintain competitive pricing.

Meanwhile, software providers specializing in analysis and visualization have reevaluated licensing models to offset increased operational expenses. End users including research institutes and hospitals are negotiating longer-term service agreements to lock in favorable rates despite market volatility. Although these tariff measures present headwinds, they simultaneously create incentives for local assembly and innovation in component design, reinforcing resilience across North American operations.

Unveiling Core Market Segmentation Patterns

A nuanced view of market segmentation reveals distinct growth trajectories across product types, technologies, applications, and end users. Devices such as imaging, monitoring, and therapeutic systems are each subdivided into highly specialized categories that cater to diverse clinical and research needs. Within imaging, computed tomography, electroencephalography, and magnetic resonance modalities address a spectrum of diagnostic challenges, while monitoring devices range from invasive approaches for critical care to noninvasive wearables that support long-term patient management. Therapeutic offerings split between neuromodulation and rehabilitation technologies, each targeting specific neurological conditions.

Service revenues derive from consultancy and maintenance streams that support device uptime and procedural optimization, complemented by software segments focused on analysis and visualization. Technology segmentation further delineates offerings by modality, including functional near infrared spectroscopy and magnetoencephalography alongside mainstream computed tomography and electroencephalography applications. In parallel, application areas span diagnostics of cardiovascular, neurological, and oncology imaging, real-time patient monitoring, fundamental research, and therapy modalities such as neuromodulation and rehabilitation therapy. This cross-sectional view underscores how clinics, hospitals, pharmaceutical companies, and research institutes drive demand through tailored requirements and purchasing patterns.

Mapping Regional Dynamics Driving Growth

Regional dynamics in the neuroscience market vary significantly across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, robust research funding and a mature healthcare infrastructure support rapid uptake of advanced imaging and monitoring systems. The United States continues to lead in clinical trials for novel neuromodulation therapies, while Canada emphasizes precision diagnostics through collaborative initiatives between academic centers and device manufacturers.

Across Europe Middle East & Africa, harmonized regulatory frameworks and public-private partnerships are unlocking access to cutting-edge magnetic resonance imaging platforms and software-driven analytics. Development programs in the Middle East are increasingly focused on building local expertise, whereas select African nations are investing in portable monitoring solutions to address rural healthcare gaps. Meanwhile, the Asia-Pacific region is experiencing surging demand for cost-effective imaging and rehabilitation devices, driven by aging populations in Japan and China alongside expanding research funding in Australia and South Korea. These regional subtleties shape strategic entry and expansion plans for market participants worldwide.

Profiling Leading Innovators Steering Progress

Leading corporations in the neuroscience arena are pursuing a mix of organic innovation and strategic alliances to solidify their market positions. Major imaging equipment manufacturers have expanded their portfolios through targeted acquisitions of specialist software firms, integrating advanced analytics into their hardware offerings. Meanwhile, niche device companies focused on neuromodulation and rehabilitation technologies have forged partnerships with research hospitals to accelerate clinical validation and market entry.

Simultaneously, service-oriented enterprises have escalated investments in predictive maintenance platforms, leveraging data to minimize downtime for critical monitoring devices. Software developers specializing in visualization and data interpretation are collaborating with academic institutions to enhance algorithmic accuracy and broaden application scope. This competitive interplay reflects a market where agility in technology adoption and depth of application expertise are decisive factors guiding leadership and long-term viability.

Strategic Imperatives for Industry Advancement

Industry leaders must embrace several strategic imperatives to thrive amid intensifying competition and evolving market demands. Investing in research and development across both hardware and software domains will be critical for sustaining differentiation in imaging precision and analytical performance. Cultivating partnerships with clinical and academic institutions can accelerate technology validation and create early adoption pathways for novel therapeutic modalities.

Corporate efforts should also prioritize the optimization of global supply chains to reduce tariff exposure and ensure continuity of component availability. Targeted engagement with regulatory bodies will streamline approvals for emerging technologies, while customized service agreements can foster deeper client relationships and predictable revenue streams. Finally, a proactive approach to expanding presence in high-growth regions through localized manufacturing and training programs will enhance market resilience and unlock new opportunities for revenue diversification.

Underpinning Insights Through Rigorous Research Rigor

This analysis draws upon a rigorous multi-step research methodology designed to ensure depth and accuracy. Primary interviews were conducted with leading neuroscientists, device manufacturers, and healthcare administrators to capture firsthand perspectives on technology adoption and clinical integration. Secondary data collection included peer-reviewed journals, regulatory filings, and corporate financial disclosures, allowing for comprehensive cross-validation of industry trends.

Quantitative inputs were triangulated with qualitative insights to construct a coherent narrative around segmentation performance, regional drivers, and competitive dynamics. Data quality protocols were applied at each stage to verify source credibility and consistency, while thematic analysis techniques uncovered underlying patterns across technology, application, and end-user domains. This robust framework underpins the actionable recommendations and strategic insights presented throughout this executive summary.

Synthesizing Key Findings for Informed Decision Making

The convergence of advanced imaging modalities, precise monitoring devices, and innovative therapeutic solutions has ushered in a pivotal moment for the neuroscience market. As stakeholders navigate the implications of new tariff structures, segmentation trends and regional nuances will critically shape strategic decisions. Companies that align their portfolios with the evolving demands of clinics, hospitals, pharmaceutical organizations, and research institutes stand to secure sustainable growth.

By synthesizing the effects of emerging technologies such as functional near infrared spectroscopy and magnetoencephalography with the adoption patterns across diagnostics, monitoring, research, and therapy domains, leaders can craft nuanced market approaches. The interplay between hardware innovation, service excellence, and software-driven analytics underscores the importance of integrated solutions that deliver both clinical impact and operational efficiency. This conclusion reaffirms the need for informed, agile strategies to harness the full potential of the neuroscience ecosystem.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Devices
      • Imaging Devices
        • Computed Tomography Devices
        • Electroencephalography Devices
        • Magnetic Resonance Imaging Devices
      • Monitoring Devices
        • Invasive Monitoring Devices
        • Non Invasive Monitoring Devices
      • Therapeutic Devices
        • Neuromodulation Devices
        • Rehabilitation Devices
    • Services
      • Consultancy Services
      • Maintenance Services
    • Software
      • Analysis Software
      • Visualization Software
  • Technology
    • Computed Tomography
    • Electroencephalography
    • Functional Near Infrared Spectroscopy
    • Magnetic Resonance Imaging
    • Magnetoencephalography
  • Application
    • Diagnostics
      • Cardiovascular Disorders
      • Neurological Disorders
      • Oncology Imaging
    • Monitoring
    • Research
    • Therapy
      • Neuromodulation
      • Rehabilitation Therapy
  • End User
    • Clinics
    • Hospitals
    • Pharmaceutical Companies
    • Research Institutes
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Roche Holding AG
  • Biogen Inc.
  • Novartis AG
  • Pfizer Inc.
  • Johnson & Johnson
  • AbbVie Inc.
  • Eli Lilly and Company
  • Teva Pharmaceutical Industries Ltd
  • Merck & Co., Inc.
  • Sanofi S.A.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neuroscience Market, by Product Type
8.1. Introduction
8.2. Devices
8.2.1. Imaging Devices
8.2.1.1. Computed Tomography Devices
8.2.1.2. Electroencephalography Devices
8.2.1.3. Magnetic Resonance Imaging Devices
8.2.2. Monitoring Devices
8.2.2.1. Invasive Monitoring Devices
8.2.2.2. Non Invasive Monitoring Devices
8.2.3. Therapeutic Devices
8.2.3.1. Neuromodulation Devices
8.2.3.2. Rehabilitation Devices
8.3. Services
8.3.1. Consultancy Services
8.3.2. Maintenance Services
8.4. Software
8.4.1. Analysis Software
8.4.2. Visualization Software
9. Neuroscience Market, by Technology
9.1. Introduction
9.2. Computed Tomography
9.3. Electroencephalography
9.4. Functional Near Infrared Spectroscopy
9.5. Magnetic Resonance Imaging
9.6. Magnetoencephalography
10. Neuroscience Market, by Application
10.1. Introduction
10.2. Diagnostics
10.2.1. Cardiovascular Disorders
10.2.2. Neurological Disorders
10.2.3. Oncology Imaging
10.3. Monitoring
10.4. Research
10.5. Therapy
10.5.1. Neuromodulation
10.5.2. Rehabilitation Therapy
11. Neuroscience Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Hospitals
11.4. Pharmaceutical Companies
11.5. Research Institutes
12. Americas Neuroscience Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Neuroscience Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Neuroscience Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Roche Holding AG
15.3.2. Biogen Inc.
15.3.3. Novartis AG
15.3.4. Pfizer Inc.
15.3.5. Johnson & Johnson
15.3.6. AbbVie Inc.
15.3.7. Eli Lilly and Company
15.3.8. Teva Pharmaceutical Industries Ltd
15.3.9. Merck & Co., Inc.
15.3.10. Sanofi S.A.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NEUROSCIENCE MARKET MULTI-CURRENCY
FIGURE 2. NEUROSCIENCE MARKET MULTI-LANGUAGE
FIGURE 3. NEUROSCIENCE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NEUROSCIENCE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NEUROSCIENCE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NEUROSCIENCE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEUROSCIENCE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEUROSCIENCE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NEUROSCIENCE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NEUROSCIENCE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NEUROSCIENCE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NEUROSCIENCE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NEUROSCIENCE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NEUROSCIENCE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NEUROSCIENCE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NEUROSCIENCE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NEUROSCIENCE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEUROSCIENCE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEUROSCIENCE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEUROSCIENCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NEUROSCIENCE MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEUROSCIENCE MARKET SIZE, BY COMPUTED TOMOGRAPHY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEUROSCIENCE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEUROSCIENCE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEUROSCIENCE MARKET SIZE, BY INVASIVE MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEUROSCIENCE MARKET SIZE, BY NON INVASIVE MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEUROSCIENCE MARKET SIZE, BY NEUROMODULATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEUROSCIENCE MARKET SIZE, BY REHABILITATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NEUROSCIENCE MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NEUROSCIENCE MARKET SIZE, BY CONSULTANCY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NEUROSCIENCE MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NEUROSCIENCE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NEUROSCIENCE MARKET SIZE, BY ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NEUROSCIENCE MARKET SIZE, BY VISUALIZATION SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NEUROSCIENCE MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NEUROSCIENCE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NEUROSCIENCE MARKET SIZE, BY FUNCTIONAL NEAR INFRARED SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NEUROSCIENCE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NEUROSCIENCE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NEUROSCIENCE MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL NEUROSCIENCE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL NEUROSCIENCE MARKET SIZE, BY ONCOLOGY IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL NEUROSCIENCE MARKET SIZE, BY MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL NEUROSCIENCE MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL NEUROSCIENCE MARKET SIZE, BY THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL NEUROSCIENCE MARKET SIZE, BY NEUROMODULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL NEUROSCIENCE MARKET SIZE, BY REHABILITATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL NEUROSCIENCE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL NEUROSCIENCE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL NEUROSCIENCE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL NEUROSCIENCE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS NEUROSCIENCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES NEUROSCIENCE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. CANADA NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. CANADA NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 81. CANADA NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 82. CANADA NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 83. CANADA NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 84. CANADA NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 85. CANADA NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 86. CANADA NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. CANADA NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. CANADA NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 89. CANADA NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 90. CANADA NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. MEXICO NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. MEXICO NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 93. MEXICO NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 94. MEXICO NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 95. MEXICO NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 96. MEXICO NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 97. MEXICO NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. MEXICO NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. MEXICO NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 102. MEXICO NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 154. GERMANY NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 155. GERMANY NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 156. GERMANY NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 157. GERMANY NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 158. GERMANY NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 159. GERMANY NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. GERMANY NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. GERMANY NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 162. GERMANY NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 163. GERMANY NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. FRANCE NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. FRANCE NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 166. FRANCE NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 167. FRANCE NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 168. FRANCE NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 169. FRANCE NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 170. FRANCE NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 171. FRANCE NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 172. FRANCE NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. FRANCE NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 174. FRANCE NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 175. FRANCE NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. ITALY NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. ITALY NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 190. ITALY NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 191. ITALY NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 192. ITALY NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 193. ITALY NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 194. ITALY NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 195. ITALY NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. ITALY NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. ITALY NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 198. ITALY NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 199. ITALY NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. SPAIN NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. SPAIN NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 202. SPAIN NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 203. SPAIN NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 204. SPAIN NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 205. SPAIN NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 206. SPAIN NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. SPAIN NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. SPAIN NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 210. SPAIN NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 211. SPAIN NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. DENMARK NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. DENMARK NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 250. DENMARK NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 251. DENMARK NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 252. DENMARK NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 253. DENMARK NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 254. DENMARK NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 255. DENMARK NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 256. DENMARK NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. DENMARK NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 258. DENMARK NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 259. DENMARK NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. QATAR NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 273. QATAR NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 274. QATAR NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 275. QATAR NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 276. QATAR NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 277. QATAR NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 278. QATAR NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 279. QATAR NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. QATAR NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. QATAR NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 282. QATAR NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 283. QATAR NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. FINLAND NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. FINLAND NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 286. FINLAND NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 287. FINLAND NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 288. FINLAND NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 289. FINLAND NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 290. FINLAND NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 291. FINLAND NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 292. FINLAND NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. FINLAND NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 294. FINLAND NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 295. FINLAND NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. SWEDEN NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 306. SWEDEN NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 307. SWEDEN NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 312. NIGERIA NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 313. NIGERIA NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 314. NIGERIA NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 315. NIGERIA NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 316. NIGERIA NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 317. NIGERIA NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 318. NIGERIA NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 319. NIGERIA NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. EGYPT NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 321. EGYPT NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 322. EGYPT NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 323. EGYPT NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 324. EGYPT NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 325. EGYPT NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 326. EGYPT NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 327. EGYPT NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 328. EGYPT NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. EGYPT NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 330. EGYPT NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 331. EGYPT NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 332. TURKEY NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 333. TURKEY NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 334. TURKEY NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 335. TURKEY NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 336. TURKEY NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 337. TURKEY NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 338. TURKEY NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 339. TURKEY NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 340. TURKEY NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 341. TURKEY NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 342. TURKEY NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 343. TURKEY NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 344. ISRAEL NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 345. ISRAEL NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 346. ISRAEL NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 347. ISRAEL NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 348. ISRAEL NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 349. ISRAEL NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 350. ISRAEL NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 351. ISRAEL NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 352. ISRAEL NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 353. ISRAEL NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 354. ISRAEL NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 355. ISRAEL NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 356. NORWAY NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 357. NORWAY NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 358. NORWAY NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 359. NORWAY NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 360. NORWAY NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 361. NORWAY NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 362. NORWAY NEUROSCIENCE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 363. NORWAY NEUROSCIENCE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 364. NORWAY NEUROSCIENCE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 365. NORWAY NEUROSCIENCE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 366. NORWAY NEUROSCIENCE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 367. NORWAY NEUROSCIENCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 368. POLAND NEUROSCIENCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 369. POLAND NEUROSCIENCE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 370. POLAND NEUROSCIENCE MARKET SIZE, BY IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 371. POLAND NEUROSCIENCE MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 372. POLAND NEUROSCIENCE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 373. POLAND NEUROSCIENCE MARKET SIZE, BY SERVICES, 2018-2030 (USD MIL

Companies Mentioned

The companies profiled in this Neuroscience market report include:
  • Roche Holding AG
  • Biogen Inc.
  • Novartis AG
  • Pfizer Inc.
  • Johnson & Johnson
  • AbbVie Inc.
  • Eli Lilly and Company
  • Teva Pharmaceutical Industries Ltd
  • Merck & Co., Inc.
  • Sanofi S.A.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 16.77 Billion
Forecasted Market Value ( USD ) by 2030 $ 27.45 Billion
Compound Annual Growth Rate10.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Neuroscience Market Report 2025 - Product Image

Neuroscience Market Report 2025

  • Report
  • 200 Pages
  • Global
From
North America Neuroscience Market Size, Share & Industry Trends Analysis Report By Component (Instruments, Consumables, and Software & Services), By Technology, By End User, By Country and Growth Forecast, 2023 - 2030 - Product Image

North America Neuroscience Market Size, Share & Industry Trends Analysis Report By Component (Instruments, Consumables, and Software & Services), By Technology, By End User, By Country and Growth Forecast, 2023 - 2030

  • Report
  • 140 Pages
  • North America
From
Asia Pacific Neuroscience Market Size, Share & Industry Trends Analysis Report By Component (Instruments, Consumables, and Software & Services), By Technology, By End User, By Country and Growth Forecast, 2023 - 2030 - Product Image

Asia Pacific Neuroscience Market Size, Share & Industry Trends Analysis Report By Component (Instruments, Consumables, and Software & Services), By Technology, By End User, By Country and Growth Forecast, 2023 - 2030

  • Report
  • 149 Pages
  • Asia Pacific
From
Neuroscience - Global Strategic Business Report - Product Image

Neuroscience - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Neuroscience Antibodies and Assays - Global Strategic Business Report - Product Image

Neuroscience Antibodies and Assays - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.